Références bibliographiques

• 1. Wallace, D.C., Mitochondrial diseases in man and mouse. Science, 1999. 283(5407): p. 1482-8.
• 2. Trounce, I., E. Byrne, and S. Marzuki, Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet, 1989. 1(8639): p. 637-9.
• 3. Mazat, J.P., et al., Metabolic control analysis and threshold effect in oxidative phosphorylation: implications for mitochondrial pathologies. Mol Cell Biochem, 1997. 174(1-2): p. 143-8.
• 4. Shoffner, J. and D. Wallace, in The Metabolic and Molecular Basis of Inherited Disease, B. Scriver, Sly, Valle, Editor. 1995, McGraw-Hill: New York. p. 1535-1609.
• 5. Letellier, T., et al., The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem J, 1994. 302(Pt 1): p. 171-4.
• 6. Mazat, J.P., et al., What do mitochondrial diseases teach us about normal mitochondrial functions...that we already knew: threshold expression of mitochondrial defects. Biochim Biophys Acta, 2001. 1504(1): p. 20-30.
• 7. Rossignol, R., et al., Threshold effect and tissue specificity. Implication for mitochondrial cytopathies. J Biol Chem, 1999. 274(47): p. 33426-32.
• 8. Birch-Machin, M.A., et al., An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol, 1994. 51(1): p. 35-42.
• 9. Morgan-Hughes, J.A., et al., Mitochondrial encephalomyopathies: biochemical studies in two cases revealing defects in the respiratory chain. Brain, 1982. 105(Pt 3): p. 553-82.
• 10. Vital, C., et al., [Regressive mitochondrial abnormalities in the muscular biopsy of a bicycling champion]. Arch Anat Cytol Pathol, 1993. 41(3-4): p. 145-8.
• 11. Veksler, V.I., et al., Mitochondrial respiration in myocardial biopsy samples as a criterion of postischemic recovery of the cardiac contractility. Basic Res Cardiol, 1990. 85(3): p. 307-14.
• 12. Wiedemann, F.R., et al., Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci, 1998. 156(1): p. 65-72.
• 13. Letellier, T., et al., Mitochondrial myopathy studies on permeabilized muscle fibers. Pediatr Res, 1992. 32(1): p. 17-22.
• 14. Saks, V.A., et al., Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem, 1998. 184(1-2): p. 81-100.
• 15. Kuznetsov, A.V., et al., Application of inhibitor titrations for the detection of oxidative phosphorylation defects in saponin-skinned muscle fibers of patients with mitochondrial diseases. Biochim Biophys Acta, 1997. 1360(2): p. 142-50.
• 16. Kunz, W.S., et al., Functional characterization of mitochondrial oxidative phosphorylation in saponin-skinned human muscle fibers. Biochim Biophys Acta, 1993. 1144(1): p. 46-53.
• 17. Veksler, V.I., et al., Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta, 1987. 892(2): p. 191-6.
• 18. Endo, M. and M. Iino, Specific perforation of muscle cell membranes with preserved SR functions by saponin treatment. J Muscle Res Cell Motil, 1980. 1(1): p. 89-100.
• 19. Kacser, H. and J. Burns, in Rate control of biological processes, D. Davies, Editor. 1973, Cambridge Universitiy Press: London. p. 65-104.
• 20. Kacser, H. and J.A. Burns, The control of flux. Symp Soc Exp Biol, 1973. 27: p. 65-104.
• 21. Kuznetsov, A.V., et al., Use of saponin-permeabilized muscle fibers for the diagnosis of mitochondrial diseases. Biofactors, 1998. 7(3): p. 221-3.
• 22. Kunz, W.S., A.V. Kuznetsov, and F.N. Gellerich, Mitochondrial oxidative phosphorylation in saponin-skinned human muscle fibers is stimulated by caffeine. FEBS Lett, 1993. 323(1-2): p. 188-90.
• 23. Parsons, D.F., G.R. Williams, and B. Chance, Characteristics of isolated and purified preparations of the outer and inner membranes of mitochondria. Ann N Y Acad Sci, 1966. 137(2): p. 643-66.
• 24. Fell, D., Understanding the Control of Metabolism. 1st ed. 1997, London: Portland Press Ltd. Chap. 1, 2, 3, 5, 6; 1-81 and 101-191.
• 25. Rapoport, T.A., et al., A linear steady-state treatment of enzymatic chains. A mathematical model of glycolysis of human erythrocytes. Eur J Biochem, 1974. 42(1): p. 107-20.
• 26. Atkinson, D.E., Cellular Energy Metabolism and it Regulation. 1977, New York: Academic Press.
• 27. Atkinson, D.E., Adaptations of enzymes for regulation of catalytic function. Biochem Soc Symp, 1976(41): p. 205-23.
• 28. Groen, A.K., et al., Quantification of the contribution of various steps to the control of mitochondrial respiration. J Biol Chem, 1982. 257(6): p. 2754-7.
• 29. Kuznetsov, A.V., et al., Increase of flux control of cytochrome c oxidase in copper-deficient mottled brindled mice. J Biol Chem, 1996. 271(1): p. 283-8.
• 30. Li, W. and G. Palmer, Spectroscopic characterization of the interaction of azide and thiocyanate with the binuclear center of cytochrome oxidase: evidence for multiple ligand sites. Biochemistry, 1993. 32(7): p. 1833-43.
• 31. Kunz, W.S., Control of oxidative phosphorylation in skeletal muscle. Biochim Biophys Acta, 2001. 1504(1): p. 12-9.
• 32. Lowry, O., et al., Protein measurement with the Folin phenol reagent. J Biol Chem, 1951. 193: p. 265-275.
• 33. Smith, P.K., et al., Measurement of protein using bicinchoninic acid. Anal Biochem, 1985. 150(1): p. 76-85.
• 34. Stanley, C.A., et al., Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol, 1991. 30(5): p. 709-16.
• 35. Pons, R. and D.C. De Vivo, Primary and secondary carnitine deficiency syndromes. J Child Neurol, 1995. 10 Suppl 2: p. S8-24.
• 36. Touma, E.H. and C. Charpentier, Medium chain acyl-CoA dehydrogenase deficiency. Arch Dis Child, 1992. 67(1): p. 142-5.
• 37. McGarry, J.D. and D.W. Foster, An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res, 1976. 17(3): p. 277-81.
• 38. Motulsky, H., in Intuitive statistics. 1995, Oxford University Press. p. 31-38.
• 39. Murat, I., V.I. Veksler, and R. Ventura-Clapier, Effects of halothane on contractile properties of skinned fibers from cardiomyopathic animals. J Mol Cell Cardiol, 1989. 21(12): p. 1293-304.
• 40. Riou, B., et al., Myocardial effects of propofol in hamsters with hypertrophic cardiomyopathy. Anesthesiology, 1995. 82(2): p. 566-73.
• 41. Letellier, T., M. Malgat, and J.P. Mazat, Control of oxidative phosphorylation in rat muscle mitochondria: implications for mitochondrial myopathies. Biochim Biophys Acta, 1993. 1141(1): p. 58-64.
• 42. Magistris, M.R., et al., Needle muscle biopsy in the investigation of neuromuscular disorders. Muscle Nerve, 1998. 21(2): p. 194-200.
• 43. Gellerich, F.N., et al., The influence of the cytosolic oncotic pressure on the permeability of the mitochondrial outer membrane for ADP: implications for the kinetic properties of mitochondrial creatine kinase and for ADP channelling into the intermembrane space. Mol Cell Biochem, 1994. 133-134: p. 85-104.
• 44. Herzberg, N.H., et al., Cultured human muscle cells and respiratory chain deficiencies. Neuromuscul Disord, 1994. 4(1): p. 3-11.